LIAO XIBIN has a total of 15 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are JANSSEN R&D IRELAND, ENYO PHARMA and JANSSEN R & D IRELAND.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Liao Xibin | 15 |
#2 | Zhou Yubo | 7 |
#3 | Gao Anhui | 7 |
#4 | Li Jia | 7 |
#5 | Lu Zhijian | 7 |
Publication | Filing date | Title |
---|---|---|
WO2020150681A1 | Bruton's tyrosine kinase inhibitors | |
WO2020081690A1 | 6-mercaptopurine nucleoside analogues | |
CA3093706A1 | Jak inhibitors | |
CN110494433A | Bruton's tyrosine kinase inhibitor |